Status report
Get it in writing
The official USPTO status record for XCELLIT, serial 97664408, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELLITSerial 97664408 · Principal Register
Live · Registered
Owner: LAKEFRONT BIOTHERAPEUTICS NV
Class 009 - Electrical & Scientific Apparatus
Class 010 -
Class 042 - Scientific & Technology Services
Class 044 - Medical & Beauty Services
Filed Nov 05, 2022
Registered Feb 27, 2024
The record shows that XCELLIT is a live, Principal Register trademark owned by LAKEFRONT BIOTHERAPEUTICS NV, registered on Feb 27 2024 after filing on Nov 5 2022. The registration covers software used as a medical monitoring and control tool for coordinating chimeric antigen receptor T‑cell therapy (Class 009), medical apparatus and instruments for cell and gene therapy production and analysis (Class 010), cloud‑based SaaS versions of that software (Class 042), and related medical services such as cell‑therapy evaluation and treatment (Class 044). A similar name would raise the closest concern in the same medical‑technology and cell‑therapy space; uses outside those areas are not automatically covered by this record. The prosecution history shows a standard examination, amendment, and approval process but does not involve the Supplemental Register. The latest meaningful event is the registration confirmation on Feb 27 2024, and the supplied history shows no oppositions, cancellations or other enforcement activity. I'd treat this as a meaningful concern if you plan a name in the biotech‑therapy field.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.